Inteligencia IAMay 15, 2026Inteligencia IA
Articulo
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.
The company is developing novel therapies to overcome resistance to cancer immunotherapy.
Redaccion Data Cube AIFuente: PR Newswire
01
Resumen fuente
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.
02